Labelling of veterinary drugs

(1) All veterinary drugs intended for retail sale in Belize shall be clearly labelled in English with at least the following information– (a) the commercial names of the drug or its conventional name; (b) the qualitative, quantitative and pharmacologic composition of the drug, including its active and inactive ingredients; (c) the presentation of the packaging of the drug; (d) the uses and indications of the drug; (e) the volume and weight of the drug; Belize Agricultural Health Authority [CAP. 211 97 (f) the expiry date of the drug; (g) the dosage per species, including the method of administration and use, and the instructions of use; (h) the registration number of the drug in Belize; (i) any contraindications, warnings, and antidotes (if any); (j) the words “for veterinary use” displayed conspicuously on the packaging of the drug; (k) the batch or lot number of the drug; (l) the total quantity of the drug in each package or unit; (m) any other precautionary information and measures respecting the use of the drug; (n) the name of the manufacturer of the drug and the drug’s country of origin; (o) any applicable conditions of storage and preservation; (p) applicable withdrawal periods for meat, milk, and other types of food. (2) The information referred to in subregulation (1) may be attached on the label to the drug or on the information leaflet in respect of the drug included in the packaging of the drug.